Tirzepatide 30mg

Description

TIRZEPATIDE

GLP-TIRZ — Research Dual Incretin Agonist (GLP-1 / GIP) – 30 MG

GLP-TIRZ is a research-use-only peptide analog designed to interact with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor pathways. It is supplied exclusively for non-clinical laboratory research focused on dual-incretin signaling and metabolic pathway investigation.

Research Focus (Non-Clinical):

• Dual-receptor pathway modeling involving GLP-1R and GIPR signaling synergy
• Metabolic research models evaluating glucose regulation and energy balance pathways
• Exploratory combination research strategies involving incretin-pathway agents

Notes for Investigators:

This compound is intended for controlled laboratory research examining multi-hormonal modulation of metabolic signaling pathways. Public-facing materials intentionally avoid clinical or therapeutic positioning.

Regulatory & Use:

• For laboratory research use only
• Not a drug, food, cosmetic, or medical device
• Not for human or veterinary use
• No therapeutic, diagnostic, or dosing claims are made